Plant ID: NPO18777
Plant Latin Name: Endiandra anthropophagorum
Taxonomy Genus: Endiandra
Taxonomy Family: Lauraceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
NR3C1; | |
SLC1A2; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Nuclear hormone receptor subfamily 3 group C | NR3C1 | Glucocorticoid receptor | P04150 | CHEMBL2034 |
SLC superfamily of solute carriers | SLC1A2 | Excitatory amino acid transporter 2 | P43004 | CHEMBL4973 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0006352; DNA-templated transcription, initiation | 2.111E-02 | 1.000E+00 | NR3C1 |
BP | GO:0009987; cellular process | GO:0031668; cellular response to extracellular stimulus | 2.193E-02 | 1.000E+00 | SLC1A2 |
BP | GO:0050896; response to stimulus | GO:0048545; response to steroid hormone | 2.255E-02 | 1.000E+00 | NR3C1 |
BP | GO:0032502; developmental process | GO:0007568; aging | 2.378E-02 | 1.000E+00 | SLC1A2 |
BP | GO:0009987; cellular process | GO:0071363; cellular response to growth factor stimulus | 2.521E-02 | 1.000E+00 | NR3C1 |
BP | GO:0065007; biological regulation | GO:0001505; regulation of neurotransmitter levels | 2.623E-02 | 1.000E+00 | SLC1A2 |
BP | GO:0051179; localization | GO:0046942; carboxylic acid transport | 2.766E-02 | 1.000E+00 | SLC1A2 |
CC | GO:0044464; cell part | GO:0030673; axolemma | 1.656E-03 | 1.000E+00 | SLC1A2 |
CC | GO:0043226; organelle | GO:0016607; nuclear speck | 3.784E-02 | 1.000E+00 | NR3C1 |
MF | GO:0005215; transporter activity | GO:0015081; sodium ion transmembrane transporter activity | 1.619E-02 | 1.000E+00 | SLC1A2 |
MF | GO:0005488; binding | GO:0001047; core promoter binding | 1.732E-02 | 1.000E+00 | NR3C1 |
MF | GO:0005215; transporter activity | GO:0015291; secondary active transmembrane transporter activity | 2.490E-02 | 1.000E+00 | SLC1A2 |
MF | GO:0140110; transcription regulator activity | GO:0001077; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding | 2.807E-02 | 1.000E+00 | NR3C1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05014 | Amyotrophic lateral sclerosis (ALS) | 5.094E-03 | 1.528E-02 | SLC1A2 |
09150 Organismal Systems | 09156 Nervous system | hsa04724 | Glutamatergic synapse | 1.137E-02 | 1.705E-02 | SLC1A2 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 2.751E-02 | 2.751E-02 | NR3C1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
L00-L99: Diseases of the skin and subcutaneous tissue | Eczema | L20-L30 | NR3C1; |
H60-H95: Diseases of the ear and mastoid process | Otitis externa | H60 | NR3C1; |
G00-G99: Diseases of the nervous system G00-G99 | Multiple scierosis | G35 | NR3C1; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | NR3C1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Dermatological disease | L00-L99 | NR3C1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | NR3C1; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Spinal cord injury | S14, S24, S34 | NR3C1; |
H00-H59: Diseases of the eye and adnexa | Ocular disease | H00-H59 | NR3C1; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | NR3C1; |
G00-G99: Diseases of the nervous system G00-G99 | Ataxia telangiectasia | G11.3 | NR3C1; |
J00-J99: Diseases of the respiratory system | Rhinitis | J00, J30, J31.0 | NR3C1; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Skin allergies | T78.4 | NR3C1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Severe mood disorders | F30-F39 | NR3C1; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | NR3C1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | NR3C1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NR3C1; |
NA: NA | Corticosteroid-responsive inflammation | NA | NR3C1; |
NA: NA | Non-infectious rhinitis | NA | NR3C1; |
C00-D49: Neoplasms | Cancer | C00-C96 | NR3C1; |
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | NR3C1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | NR3C1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Xerophthalmia | E50.6-E50.7 | NR3C1; |
L00-L99: Diseases of the skin and subcutaneous tissue | Dermatitis | L20-L30 | NR3C1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Depression | F30-F39 | NR3C1; |
J00-J99: Diseases of the respiratory system | Allergic rhinitis | J00, J30, J31.0, T78.4 | NR3C1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Cushing's disease | E24.0 | NR3C1; |
G00-G99: Diseases of the nervous system G00-G99 | Duchenne muscular dystrophy | G71.0 | NR3C1; |